Preliminary in vitro data from our lab supports this hypothesis, as overexpression of MAGEC3 results in a reduction in BRCA2 protein level in both fibrosarcoma (HT1080) and ovarian cancer (SKOV3) cell lines [56]. Here, MAGEC3 is linked to ovarian carcinoma.